tetano
Editor, Senior Moderator
Pulm Med. 2012;2012:306207. Epub 2012 Jan 4.
Perspectives of Pulmonologists on the 2009-2010 H1N1 Vaccination Effort.
Clark SJ, Cowan AE, Wortley PM.
Source
Child Health Evaluation and Research (CHEAR) Unit, University of Michigan, 300 N Ingalls, Room 6E06, Ann Arbor, MI 48109-5456, USA.
Abstract
Persons with high-risk conditions such as asthma were a target group for H1N1 vaccine recommendations. We conducted a mailed survey of a national sample of pulmonologists to understand their participation in the 2009-2010 H1N1 vaccine campaign. The response rate was 59%. The majority of pulmonologists strongly recommended H1N1 vaccine for children (73%) and adults aged 25-64 years (51%). Only 60% of respondents administered H1N1 vaccine in their practice compared to 87% who offered seasonal influenza vaccine. Other than vaccine supply, respondents who provided H1N1 vaccine reported few logistical problems. Two-thirds of respondents would be very likely to vaccinate during a future influenza pandemic; this rate was higher among those who provided H1N1 vaccine and/or seasonal flu vaccine. In total, the H1N1 vaccine-related experiences of pulmonologists seemed to be positive. However, additional efforts are needed to increase participation in future pandemic vaccination campaigns.
PMID:
22272372
[PubMed - in process]
PMCID: PMC3261484
Free PMC Article
http://www.ncbi.nlm.nih.gov/pubmed/22272372
Perspectives of Pulmonologists on the 2009-2010 H1N1 Vaccination Effort.
Clark SJ, Cowan AE, Wortley PM.
Source
Child Health Evaluation and Research (CHEAR) Unit, University of Michigan, 300 N Ingalls, Room 6E06, Ann Arbor, MI 48109-5456, USA.
Abstract
Persons with high-risk conditions such as asthma were a target group for H1N1 vaccine recommendations. We conducted a mailed survey of a national sample of pulmonologists to understand their participation in the 2009-2010 H1N1 vaccine campaign. The response rate was 59%. The majority of pulmonologists strongly recommended H1N1 vaccine for children (73%) and adults aged 25-64 years (51%). Only 60% of respondents administered H1N1 vaccine in their practice compared to 87% who offered seasonal influenza vaccine. Other than vaccine supply, respondents who provided H1N1 vaccine reported few logistical problems. Two-thirds of respondents would be very likely to vaccinate during a future influenza pandemic; this rate was higher among those who provided H1N1 vaccine and/or seasonal flu vaccine. In total, the H1N1 vaccine-related experiences of pulmonologists seemed to be positive. However, additional efforts are needed to increase participation in future pandemic vaccination campaigns.
PMID:
22272372
[PubMed - in process]
PMCID: PMC3261484
Free PMC Article
http://www.ncbi.nlm.nih.gov/pubmed/22272372